Drug company recalls bottles of Excedrin, NoDoz
Written on February 2, 2012 by George Moowattin
The news follows Novartis’ recent decision to temporarily suspend production at its Lincoln, Neb., plant for “maintenance and other improvement activities.”
The Swiss drug maker said it implemented the recall, which affects U.S. retailers, voluntarily and is working with the Food and Drug Administration during the process. It became aware of the potential problem during an internal review that identified broken and chipped pills, and inconsistent bottle packaging that could cause pills to be mixed up.
The company said it wanted to make sure that customers didn’t take any pills that they might be allergic to or that might become dangerous when mixed with their other medications, though it also said that there have been no such reports from consumers.
Novartis said that some of the bottles of headache medicine Excedrin and caffeine caplets NoDoz with expiration dates of Dec.
High costs and the alarmingly high number of accidental deaths linked to prescription pain pills have made pain treatment a central issue in health care across Ohio and the nation. especially children and the elderly who sometimes cannot express their needs. especially chronic pain. often linked to cases of drug abuse — and to student observation of patients. even those with the same injury or illnesses — perceive twinging, throbbing, aching or soreness very differently. such as that accompanying burns or kidney stones — should be treated immediately. 
With another decisive victory under his belt it appears UFC featherweight champ Jose Aldo is running out of legitimate threats to his title, taking out undefeated Chad Mendes at UFC 142 with a first round knockout after picking apart Mark Hominick and Kenny Florian in his previous defenses of his belt. In fact, the situation is such UFC President Dana White has come out to say he’s completely open to the idea of Aldo abandoning his strap and moving up to 155 pounds. H